research use only
Cat.No.S4245
|
In vitro |
Water : 40 mg/mL
DMSO
: 2 mg/mL
(10.09 mM)
Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 198.11 | Formula | C6H7NaO6 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 134-03-2 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Sodium Vitamin C | Smiles | C(C(C1C(=C(C(=O)O1)O)[O-])O)O.[Na+] | ||
| In vitro |
Sodium ascorbate has a growth inhibiting action only at high concentrations in cultured human neoplastic cell lines MCF-7 (breast carcinoma), KB (oral epidermoid carcinoma), and AN3-CA (endometrial adenocarcinoma). This compound combined with vitamin K3 demonstrates a synergistic inhibition of cell growth at 10 to 50 times lower concentrations in cultured human neoplastic cell lines MCF-7, KB, and AN3-CA, at this level separately given vitamins are not toxic. This tumor cell growth inhibitory effect is completely suppressed by the addition of catalase to the culture medium containing vitamins C and K3, suggesting an excessive production of hydrogen peroxide as being implied in mechanisms responsible for the above-mentioned effects. This chemical combined with vitamin K3 results in a synergistic effect on growth inhibition in cultured human endometrial adenocarcinoma (AN3CA) cells. It results in a rapid increase in the intracellular concentration of Ca2+ ions and subsequent apoptotic cell death in HL-60 cells, characterized by cell shrinkage, nuclear fragmentation and cleavage of internucleosomal DNA to yield fragments that are multiples of 180-200 base pairs, are induced. This compound (100 μM) induces DNA single-strand breaks in human cells, Fibroblasts and Molt-4 cells are significantly more sensitive than lymphocytes. It (50 μM) results in significant cell loss in Molt-4 cells, but not in lymphocyte and fibroblast cultures.
|
References |
|
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05842382 | Not yet recruiting | Pneumonia |
Clinical Research Centre Malaysia|Ain Medicare Sdn Bhd |
December 2023 | Phase 2 |
| NCT04634227 | Recruiting | Sarcoma|Soft Tissue Sarcoma|Unresectable Soft Tissue Sarcoma|Metastatic Bone Tumor|Bone Sarcoma |
Mohammed Milhem MBBS|University of Iowa |
November 24 2020 | Early Phase 1 |
| NCT03508726 | Active not recruiting | Soft Tissue Sarcoma |
Mohammed Milhem|University of Iowa |
June 27 2019 | Phase 1|Phase 2 |
| NCT02107976 | Recruiting | Diabetes Type 2 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC) |
June 14 2019 | Phase 1 |
| NCT03123107 | Completed | Coronary Artery Bypass Graft Surgery |
Geisinger Clinic|Wilkes University |
July 6 2017 | Phase 1 |
| NCT02460783 | Completed | Alzheimer''s Disease|Obesity|Diabetes Mellitus |
National Institute on Aging (NIA)|National Institutes of Health Clinical Center (CC) |
June 22 2015 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.